---
title: "Happen delivers solid Q2 earnings beat; stock jumps"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293976877.md"
description: "Happen (HAPN) stock rose 3.9% after Q2 earnings beat expectations, driven by robust loan originations reaching $3.15B. GAAP EPS was $0.50 vs. $0.42 consensus, with net revenue at $262.9M. The company raised full-year GAAP EPS guidance to $1.80-$1.90 and projected Q3 EPS of $0.43-$0.48. CEO Scott Sanborn highlighted record pre-tax income of $75.7M and strong performance in the home improvement market."
datetime: "2026-07-27T21:20:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293976877.md)
  - [en](https://longbridge.com/en/news/293976877.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293976877.md)
---

# Happen delivers solid Q2 earnings beat; stock jumps

Happen (HAPN) stock rose 3.9% in Monday after-hours trading after the company formerly called LendingClub posted Q2 results that beat across the board, driven by robust loan originations. The online lender now expects full-year GAAP EPS of $1.80-$1.90 (midpoint $1.85) vs. $1.75 consensus and up from its previous guidance of $1.65-$1.80. Loan origin...

### Related Stocks

- [HAPN.US](https://longbridge.com/en/quote/HAPN.US.md)
- [LC.US](https://longbridge.com/en/quote/LC.US.md)

## Related News & Research

- [Happen CFO Andrew LaBenne sells 13,929 common shares for $269,812.85](https://longbridge.com/en/news/295716530.md)
- [Enveric Biosciences GAAP EPS of -$0.76](https://longbridge.com/en/news/296075035.md)
- [Quantum BioPharma GAAP EPS of -$0.47](https://longbridge.com/en/news/295931268.md)
- [BrainStorm Cell Therapeutics GAAP EPS of -$0.35](https://longbridge.com/en/news/296069988.md)
- [XP Non GAAP EPS of R$2.67, revenue of R$4.88B](https://longbridge.com/en/news/296141910.md)